
Why do we own CSL

Formerly Commonwealth Serum Laboratories before its privatisation by the Federal Government in 1994, biotechnology giant CSL is one of Australia’s most successful companies. CSL is a global leader in biotherapies, offering a broad range of blood plasma therapies essential for treating patients with immunodeficiency and autoimmune diseases, bleeding disorders, cardiac surgery patients and shock and burn victims. Recognising the critical need for plasma, CSL has adopted a vertically integrated approach, owning over 30% of blood collection centres worldwide.
Additionally, CSL is the world’s second-largest influenza vaccine manufacturer and produces a wide range of other vaccines and anti-venoms. The recent acquisition of Vifor expands its reach into the growing kidney disease treatment market.
CSL thrives in expanding markets due to its scale efficiency, high return on capital, strong balance sheet, and robust R&D pipeline. Investing over $1 billion annually in R&D, CSL has a strong record of successful product launches. Post-COVID expansion in plasma capacity and its global presence should drive organic growth and improve profit margins, particularly in its Vifor kidney disease business.
ASX-listed CSL Limited is a key direct holding of the Evidentia Quality Core Portfolio, which is held in the Partners Medium Term, Long Term, and Multi-Asset Income Portfolios.
Ironbark Advice is the sponsor of the Partners Portfolios. Ironbark Advice is comprised of the following wholly owned entities of Ironbark: Advice First Pty Ltd, Advisory Group Pty Ltd, ARTT Group Pty Ltd, Brisbane Financial Services Pty Ltd, Elevate Financial Solutions Pty Ltd, Emohruo Financial Services Pty Ltd, Invest Blue Armidale Pty Ltd, Invest Blue Brisbane Pty Ltd, Invest Blue Coffs Harbour Pty Ltd, Invest Blue Direct Pty Ltd, Invest Blue Gladstone Pty Ltd, Ogilvie Financial Services Pty Ltd, TDT (Tas) Pty Ltd, The Bravien Group Pty Ltd, Vintage Wealth Pty Ltd and Wainscott Financial Planning & Advice Pty Ltd, trading as Ironbark Advice are authorised representatives and credit representatives of Akumin Financial Planning Pty Limited, Australian Financial Services Licence and Australian Credit Licence No. 232706. Countrywide Advice Pty Ltd and GrowUp Financial Pty Ltd trading as Ironbark Advice are authorised representatives and credit representatives of Charter Financial Planning Limited, Australian Financial Services Licence and Australian Credit Licence No. 234665. GR & LC Thompson Pty Ltd trading as Ironbark Advice, is an authorised representative and credit representative of Hillross Financial Services Limited, Australian Financial Services Licence and Australian Credit Licence No. 232705. LFC Advice Pty Ltd (ABN 19 647 509 466) trading as Ironbark Advice, is a Corporate Authorised Representative of LFC Group Pty Ltd (ABN 35 644 576 965), AFSL 526600.